Colorectal cancer is one of the most common cancers to cause death. A PET scan improves prognosis and changes management of recurrent colorectal cancer in more than half of patients according to a latest study from Australia. Therefore, the data suggest to conduct nuclear imaging in cancer treatment more often.
Seasons change - and so does our mood. When days become shorter and hours of sunlight become fewer some of us suffer from seasonal depression. Brain scans taken at different times of the year brings it to light: sun makes happy.…
Atlanta-based Velocity Medical Solutions launched VelocityAI, its new molecular imaging software, at the 2008 American Association of Physicists Medicine (AAPM) in July.
An emerging discipline of noninvasive cardiac imaging, molecular imaging, has evolved constantly in the last few years and is increasingly being translated from the preclinical to the clinical level. Molecular imaging allows for unique insights into specific disease mechanisms and holds great promise to change the practice of cardiovascular medicine by facilitating early disease detection,…
With the help of an engineered common cold virus spreadings of prostate cancer in the pelvic lymph nodes can be visualised with a PET scanner. It is now possible to treat the cancer in an early stage. But the developers of the virus from UCLA's Jonsson Comprehensive Cancer Center see a chance to even use it as a treatment option.
Designed by a team of radiologists, the latest release of OsiriX 3.0.1 on the Mac Pro 8-core was demonstrated for the first time at the recent European Congress of Radiology (ECR). OsiriX - a powerful image processing software dedicated to DICOM images (.dcm / DCM extension) produced by imaging equipment (MRI, CT, PET, PET-CT etc.) and confocal microscopy (LSM and BioRAD-PIC format) - a…
The purchasing and distribution of refurbished equipment was left to specialist retailers for years, until leading manufacturers - for reasons of quality as well as image - established themselves in this business sector. The difference is that these manufacturers not only sell used equipment but also extensively refurbished systems.
Can they replace PET? By Marco Essig MD, Professor of Radiology at the German Cancer Research Centre, outlines relevant presentations at the ECR.
Andrea Martini and Joerg Larsen, of the Institute for Roentgendiagnostics, Braunschweig Teaching Hospitals, Germany, discuss nanotechnology, hybrid imaging and the quest for a personalised medicine.
Amyloidb (Ab) plaque formation is a hallmark of Alzheimers disease (AD) and precedes the onset of dementia. Australian researchers reported the first data on the validity in humans of a new PET tracer binding to Ab. Their data suggest that 18F-BAY94-9172 of Bayer Schering Pharma AG can reliably detect Ab deposition and thereby aid early diagnosis, differential diagnosis, and therapeutic…
Agfa Healthcare's new IMPAX solution suites offer PACS and RIS to cover hospital data handling and cardiovascular, cardiology, orthopaedics, mammography and radiology data.
PET/CT imaging exhibits significantly higher sensitivity, specificity and accuracy than conventional imaging when it comes to detecting malignant tumours in children, according to research published in the Journal of Nuclear Medicine (12/07).
For individualised radiotherapy, high-precision delineation and characterisation of the tumour is critical. If highest radiation doses are delivered in a targeted fashion, the chance of tumour cell kill increases and tumour control probability is enhanced.
The Virtual Physiological Human By Hans-Ulrich Kauczor MD PhD, Director and Chairman of Radiology at Heidleburg University Clinic, and radiologists Frederik Giesel MD MBA and Hendrik von Tengg-Kobligk MD of the German Cancer Research Centre in Heidleburg, Germany.
A multi-institutional study recently compared whether positron emission tomography (PET) or computed tomography (CT) performs more efficient in the characterization of solitary lung nodules (SPNs). Previously performed studies were either limited by small sample sizes or carried out more than a decade ago with outdated technology and methods.
Visual analysis of PET scans for non-Hodgkin lymphoma may be improved by using standardised uptake value in monitoring response to treatment, according to research published in the Journal of Nuclear Medicine.
Carestream's molecular imaging group focuses on life sciences, developing high-performance digital imaging systems, imaging agents, film and accessories for the research and drug discovery/development markets.
Dr Thomas Beyer: `PET/CT is a non-invasive imaging modality that captures anatomical and metabolic data in a single scan´
The Technology initiative “Molecular Imaging” aims to strengthen the synergies of science and industry in research and development of new technologies in order to significantly improve diagnostic and treatment options, for example for cardiovascular diseases, cancer or Alzheimer's.
The Forum Medizintechnik-Pharma - an association that provides a recognised contribution to the development of the co-operative environment in medicine, technology and pharmaceuticals, met for a symposium in Germany this July.
The next-generation of hybrid imaging technology was presented at this years SNM meeting in Washington, D.C: The first human brain images from a prototype PET/MRI system, which is developed by a collaborative team of German and US researchers from the Universities of Tübingen and Tennessee, as well as Siemens Medical Solutions.
For decades, non-invasive cardiac assessment has been at the center of interest. Non-invasive imaging modalities, such as MSCT, MRI, SPECT, PET, and echocardiography, provide valuable cardiac information, and all have been used to measure cardiac morphology, function, perfusion, viability of myocardium, and coronary anatomy for clinical management and research. The last decade brought major…
'If you want to find a needle in a haystack, X-ray is a good tool. Now imagine how much easer that would be if the needle could glow.'
This was the motto of the ECR 2007 in Vienna, where a group of high-ranking experts discussed diseases of the 21st century; research competition between the US and Europe; the conditions needed to progress leading medical R&D - moderated by Congress President Professor Christian J Herold.
When the Siemens board of directors announced its decision for the new Siemens CEO on Sunday, the economic world was surprised: Not only that the name Peter Löscher was never mentioned in the previous discussions about a successor of Klaus Kleinfeld, but hardly anybody knew Loescher´s name in any enconomic context.